Original Article Pain Management Pulmonology Radiation Oncology
Effect of delayed cord clamping on length of stay among patients with heart failure

Effect of delayed cord clamping on length of stay among patients with heart failure

Authors

Malik Kaur

Malik Kaur

St Thomas' Hospital, Pitcairn Island

Corresponding

Published

June 23, 2026

Paper ID

PAP-000013

Status

Published

DOI

10.65712/tmj.test000271

Effect of delayed cord clamping on length of stay among patients with heart failure

Advance Services

Create Content

Video • Presentation • Poster

From $97.00 per format

Abstract

Background: Guidelines make only a weak recommendation on delayed cord clamping. Methods: We conducted a systematic review and meta-analysis across 14 centres between 2016 and 2022. Results: Serious adverse events were rare and similar between groups. length of stay occurred in 6% of the intervention group versus 12% of controls. Conclusion: Future work should test delayed cord clamping in a pragmatic multicentre trial.

Introduction

Guidelines make only a weak recommendation on delayed cord clamping. Earlier studies of delayed cord clamping were small or single-centre. Practice around delayed cord clamping varies widely between centres.

Earlier studies of delayed cord clamping were small or single-centre. The cost of length of stay to health systems is substantial. Guidelines make only a weak recommendation on delayed cord clamping.

Materials and Methods

We conducted a systematic review and meta-analysis across 12 centres between 2017 and 2025. Missing data were handled with multiple imputation. Eligible participants were patients with heart failure. Analyses were adjusted for age, sex and baseline severity.

The primary outcome was length of stay, assessed blind to allocation. Eligible participants were patients with heart failure. Analyses were adjusted for age, sex and baseline severity.

Results

Serious adverse events were rare and similar between groups. length of stay occurred in 7% of the intervention group versus 33% of controls.

GroupnEvents
Age < 6521083
Age < 65514115
Age ≥ 6541462
Intervention89277
TABLE 1: Secondary outcomes
Values are n (%) unless stated otherwise.
Figure 1
FIGURE 1: Change in length of stay
Shown for patients with heart failure; error bars are 95% confidence intervals.
Figure 2
FIGURE 2: Change in length of stay
Shown for patients with heart failure; error bars are 95% confidence intervals.

Serious adverse events were rare and similar between groups. Effects were consistent across prespecified subgroups.

Effects were consistent across prespecified subgroups. Serious adverse events were rare and similar between groups. 2474 participants were included (median age 72 years). 1645 participants were included (median age 70 years).

Discussion

Residual confounding cannot be excluded. These findings suggest that delayed cord clamping is associated with better length of stay in patients with heart failure. Strengths include the sample size and blinded outcome assessment.

Strengths include the sample size and blinded outcome assessment. Future work should test delayed cord clamping in a pragmatic multicentre trial. Implementation will depend on staffing, cost and local protocols. Residual confounding cannot be excluded.

Conclusions

Delayed cord clamping may be offered for patients with heart failure to improve length of stay.

References

1. Herrera U, Okafor P, et al. Delayed cord clamping and ventilator-free days. Eur Heart J. 2011;70(7):510-1262.

2. Nasser H, Silva T, et al. Telemedicine follow-up and 30-day readmission. N Engl J Med. 2009;15(1):550-1709.

3. Nasser M, Mensah P, et al. Home-based cardiac rehabilitation and health-related quality of life. JAMA. 2021;46(1):352-994.

4. Nakamura W, Herrera J, et al. A sepsis alert system and chronic pain scores. BMJ. 2024;340(11):441-1287.

5. Nakamura K, Silva C, et al. Continuous glucose monitoring and chronic pain scores. JAMA. 2009;311(4):496-1303.

6. Nakamura T, Haddad A, et al. Delayed cord clamping and medication adherence. Crit Care Med. 2010;256(3):680-1426.

7. Ahmed Y, Kowalski D, et al. SGLT2 inhibitors and glycaemic control. Ann Intern Med. 2016;176(12):361-1398.

8. Larsen R, Costa F, et al. SGLT2 inhibitors and surgical site infection. JAMA. 2009;313(1):451-1182.

9. Haddad E, Moreau G, et al. Home-based cardiac rehabilitation and glycaemic control. Pediatrics. 2021;165(8):821-1680.

Appendices

Ethics approval: IRB-1130.